FDA NDC Directory · JSON-LD · Markdown

Oxybutynin Chloride

NDC 42291-456 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAvKARE
Marketing categoryAbbreviated NDA (generic) · App ANDA208165
Dosage form / routeTABLET · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (5 mg/1)
Marketing started20250501
Package count1

External sources

Source: openFDA. Public-domain (CC0).